Scarica l'app Stockscreener
13.59
8.79%
-1.31
Precedente Chiudi:
$14.90
Aprire:
$14.94
Volume 24 ore:
3.14M
Relative Volume:
1.77
Capitalizzazione di mercato:
$1.21B
Reddito:
$-249.00K
Utile/perdita netta:
$-187.60M
Rapporto P/E:
-5.436
EPS:
-2.5
Flusso di cassa netto:
$-201.88M
1 W Prestazione:
+0.82%
1M Prestazione:
+44.88%
6M Prestazione:
+283.90%
1 anno Prestazione:
+319.44%
Intervallo 1D:
$13.57
$15.14
Intervallo di 1 settimana:
$13.41
$15.14
Portata 52W:
$2.865
$15.14
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
Nome
Amylyx Pharmaceuticals Inc
Settore
Industria
Telefono
617-683-0917
Indirizzo
43 THORNDIKE STREET, CAMBRIDGE
Confronta AMLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals Inc
|
13.59 | 1.59B | -249.00K | -187.60M | -201.88M | -2.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-06-24 | Iniziato | Guggenheim | Buy |
| 2025-06-17 | Iniziato | Citigroup | Buy |
| 2025-05-30 | Iniziato | TD Cowen | Buy |
| 2025-04-07 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2024-11-18 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-10-23 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-03-18 | Downgrade | Mizuho | Buy → Neutral |
| 2024-03-11 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-03-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-03-08 | Downgrade | Goldman | Buy → Neutral |
| 2024-01-03 | Iniziato | Robert W. Baird | Outperform |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-07-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-03-31 | Iniziato | Mizuho | Buy |
| 2023-01-05 | Iniziato | BofA Securities | Buy |
| 2022-05-25 | Iniziato | Citigroup | Buy |
| 2022-04-01 | Downgrade | Goldman | Buy → Neutral |
Mostra tutto
Amylyx Pharmaceuticals Inc Borsa (AMLX) Ultime notizie
Visual analytics tools that track Amylyx Pharmaceuticals Inc. performanceJuly 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
H.C. Wainwright, Leerink Partners, and TD Cowen Reaffirm ‘Buy’ Ratings on Amylyx Pharmaceuticals, Inc. (AMLX) - MSN
How supply chain issues affect Amylyx Pharmaceuticals Inc. stockWeekly Risk Report & Consistent Profit Alerts - newser.com
Amylyx Pharmaceuticals Reaches Analyst Target Price - Nasdaq
Why Amylyx Pharmaceuticals Inc. stock attracts global investorsWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 52-Week HighWhat's Next? - MarketBeat
Will Amylyx Pharmaceuticals Inc. stock continue upward momentumJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com
Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Amylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 52-Week High Following Analyst Upgrade - MarketBeat
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives $14.50 Average PT from Brokerages - MarketBeat
Amylyx Pharmaceuticals Hits New 52-Week High of $13.09 - Markets Mojo
Amylyx stock dips after pricing $60M stock offering - MSN
Amylyx Pharmaceuticals Hits New 52-Week High of $13.33 - Markets Mojo
The Goldman Sachs Group Forecasts Strong Price Appreciation for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock - MarketBeat
Guggenheim Issues Positive Forecast for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Price - MarketBeat
Market Fear: Is Amylyx Pharmaceuticals Inc. a turnaround storyJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - خودرو بانک
Goldman Sachs Group Inc. Boosts Stake in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Layoff Watch: Whats the fair value of Amylyx Pharmaceuticals Inc stockJuly 2025 Sector Moves & Low Risk High Reward Ideas - khodrobank.com
Woodline Partners LP Takes Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
WilmerHale Advises Underwriters in Public Offering of Amylyx Pharmaceuticals - WilmerHale
Amylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 12-Month High Following Analyst Upgrade - Defense World
Market Pulse: Is Amylyx Pharmaceuticals Inc stock a good pick for beginnersSell Signal & Weekly High Conviction Ideas - خودرو بانک
Cubist Systematic Strategies LLC Cuts Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $25.00 at Guggenheim - Defense World
Dow Update: Will Aether Holdings Inc benefit from green energy policiesWeekly Profit Recap & AI Enhanced Trading Signals - khodrobank.com
Aug Reactions: Is Amylyx Pharmaceuticals Inc. showing insider buyingPortfolio Return Summary & Real-Time Volume Analysis - خودرو بانک
IPO Launch: Is Amylyx Pharmaceuticals Inc stock a buy or sell2025 Volatility Report & Low Risk Investment Opportunities - خودرو بانک
Amylyx announces proposed public offering of common stock - MSN
Amylyx Pharmaceuticals (NASDAQ:AMLX) Shares Gap UpWhat's Next? - MarketBeat
Market Outlook: Does Amylyx Pharmaceuticals Inc. have strong EBITDA marginsJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - khodrobank.com
Movement Recap: What is Amylyx Pharmaceuticals Incs debt to equity ratioTrade Entry Summary & Growth Oriented Trade Recommendations - خودرو بانک
Is Amylyx Pharmaceuticals Inc stock a good pick for beginnersIndex Update & Precise Swing Trade Alerts - خودرو بانک
Guggenheim raises Amylyx Pharmaceuticals stock price target on PBH potential - Investing.com
Amylyx Pharmaceuticals (NASDAQ:AMLX) Hits New 1-Year HighHere's Why - MarketBeat
Will Amylyx Pharmaceuticals’ (AMLX) $175 Million Capital Raise Reshape Its Pipeline Ambitions? - Yahoo Finance
Invesco Ltd. Buys Shares of 45,694 Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Amylyx Pharmaceuticals prices $175M public offering - MSN
Alyeska Investment Group L.P. Decreases Holdings in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
American Century Companies Inc. Increases Position in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Adage Capital Partners GP L.L.C. Acquires New Stake in Amylyx Pharmaceuticals, Inc. $AMLX - MarketBeat
Amylyx Pharmaceuticals Announces $164 Million Stock Offering - TipRanks
Amylyx Pharmaceuticals Inc Azioni (AMLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):